536565
TRIMURTHI
Start SIP
Invest Now
Start SIP in TRIMURTHI
Performance
- Low
- ₹62
- High
- ₹64
- 52 Week Low
- ₹25
- 52 Week High
- ₹70
- Open Price₹64
- Previous Close₹62
- Volume1,051
- 50 DMA₹57.77
- 100 DMA₹53.57
- 200 DMA₹44.94
Investment Returns
- Over 1 Month + 4.99%
- Over 3 Month + 20.28%
- Over 6 Month + 51.07%
- Over 1 Year + 163.98%
Smart Investing Starts Here Start SIP with Novelix Pharmaceuticals for Steady Growth!
Novelix Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 115.7
- PEG Ratio
- 0
- Market Cap Cr
- 112
- P/B Ratio
- 3.9
- Average True Range
- 3.07
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- 0.48
- RSI
- 63.54
- MFI
- 72.08
Novelix Pharmaceuticals Financials
Novelix Pharmaceuticals Technicals
EMA & SMA
Current Price
₹63.75
+
1.27
(2.03%)
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹59.48
- 50 Day
- ₹57.77
- 100 Day
- ₹53.57
- 200 Day
- ₹44.94
Resistance and Support
63.38
- R3 67.17
- R2 65.78
- R1 64.77
- S1 62.37
- S2 60.98
- S3 59.97
Novelix Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-13 | Quarterly Results | |
| 2025-08-14 | Quarterly Results & A.G.M. | |
| 2025-06-24 | Others | Inter alia, to consider and approve 1. The conversion of Warrants into Equity Shares of the Company. |
| 2025-05-27 | Audited Results | |
| 2025-04-12 | Others | Inter-alia, to consider 1. Convening of an EGM for appointment of Non-Executive Independent Director of the Company. 2. To appoint a scrutinizer for the upcoming EGM. 3. Other business matters. |
Novelix Pharmaceuticals F&O
About Novelix Pharmaceuticals
- NSE Symbol
- TRIMURTHI
- BSE Symbol
- 536565
- ISIN
- INE314I01036
Similar Stocks to Novelix Pharmaceuticals
Novelix Pharmaceuticals FAQs
Novelix Pharmaceuticals share price is ₹63 As on 08 February, 2026 | 11:10
The Market Cap of Novelix Pharmaceuticals is ₹112.3 Cr As on 08 February, 2026 | 11:10
The P/E ratio of Novelix Pharmaceuticals is 115.7 As on 08 February, 2026 | 11:10
The PB ratio of Novelix Pharmaceuticals is 3.9 As on 08 February, 2026 | 11:10
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.